"lnp_id","ionizable_lipid","peg_lipid_x","sterol_lipid_x","helper_lipid_x","lipid_molar_ratio_x","particle_size_nm_std","pdi_std","zeta_potential_mv_std","encapsulation_efficiency_percent_std","loading_capacity_std","target_type","nucleic_acid_sequence","peg_lipid_original","ionizable_lipid_original_x","helper_lipid_original","sterol_lipid_original","ionizable_lipid_smiles","peg_lipid_smiles","sterol_lipid_smiles","helper_lipid_smiles","synthesis_info","bioactivity_profile","paper_title","paper_authors","paper_doi","paper_journal","paper_year","0","1","2","atlas_row_id","ionizable_lipid_original_y","helper_lipid_y","sterol_lipid_y","peg_lipid_y","lipid_molar_ratio_y","count_atlas","matched_id"
226,"DLin-MC3-DMA","PEG2000","cholesterol","DSPC","25:0.75:19.25:5",,,,,,"mRNA","cre_recombinase, cas9, vegfr2","C14PEG2K","MC3","DSPC","cholesterol","CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC","synthesis_method: Similar to CAD LNPs; device_used: Similar to CAD LNPs; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: ; organic_phase_composition: ; mixing_time_sec: ; temperature_condition: ; post_processing: ; sterilization: ; storage_buffer:","animal_model: Ai14 mice, LLC-GFP lung tumor model; administration_route: intravenous (IV); dose: 0.3 mg/kg Cre mRNA, 4.0 mg/kg Cas9 mRNA/VEGFR2 sgRNA; gene_expression_result: Gold standard lung-tropic LNP control, lower performance than LNP-CAD9; biodistribution_result: Lung-targeted delivery","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"MC3",,,"Row24","MC3","DSPC","cholesterol","PEG2000","25:0.75:19.25:5",1,"Row96"
274,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","181.8 ¡¾ 4.8","0.11 ¡¾ 0.09","13.2 ¡¾ 0.4","79.8 ¡¾ 5.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 72)","C14PEG2K","12-A2-7","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","7","Row72","12-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16",1,"Row29"
